Agarwal Loveleena, Singh Amit Kumar, Agarwal Amitabh, Singh Ravinder Pal
Department of Microbiology, Mayo Institute of Medical Sciences, Barabanki, Uttar Pradesh, India.
Department of Physiology, Mayo Institute of Medical Sciences, Barabanki, Uttar Pradesh, India.
J Family Med Prim Care. 2018 Jan-Feb;7(1):157-161. doi: 10.4103/jfmpc.jfmpc_196_16.
Substantial proportion of liver diseases worldwide is caused by hepatitis B virus (HBV) and hepatitis C virus (HCV) infections which manifest not only as an acute illness but also lead to chronic sequelae. Together HBV and HCV cause chronic infection in more than 500 million persons and about one million deaths annually. Most of the people with chronic infection are not aware of the infection thus enabling it to go unnoticed, and undiagnosed and act as a potential source of infection for the community at large. Therefore, we aimed to find the prevalence of HBV and HCV in Barabanki, Uttar Pradesh among individuals attending the tertiary care hospital.
From February 2015 to January 2016, 3750 patients attending the outdoor patient departments or admitted to the indoor patient departments of teaching hospital and advised to undergo HBV and HCV for screening before any invasive/surgical procedure were included in the study. Screening was done by rapid card test followed by the confirmation of all samples by enzyme immunoassay.
Seroprevalence of HBV and HCV was found to be 3.9% and 1.76% respectively with higher seroprevalence among males and in married participants in both infections. Blood transfusion is statistically a significant risk factor for HCV infection ( < 0.05). Coinfection with HBV/HCV was seen in 0.16% of the individuals visiting the hospital.
Higher seroprevalence of HBV and HCV among the hospital-based population mandates screening of high-risk individuals. Awareness by health education of safe sexual practices and improved safety of blood and its products are among the most important preventive measures to control HBV and HCV infection.
全球相当一部分肝脏疾病是由乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染引起的,这些感染不仅表现为急性疾病,还会导致慢性后遗症。HBV和HCV共同导致超过5亿人慢性感染,每年约有100万人死亡。大多数慢性感染者并未意识到自己被感染,因此这种感染未被察觉、未被诊断,成为整个社区潜在的传染源。因此,我们旨在找出北方邦巴拉班基地区三级护理医院就诊人群中HBV和HCV的流行情况。
2015年2月至2016年1月,纳入3750例在教学医院门诊就诊或住院的患者,这些患者在进行任何侵入性/外科手术前被建议接受HBV和HCV筛查。筛查采用快速卡片检测,随后所有样本通过酶免疫测定进行确认。
HBV和HCV的血清流行率分别为3.9%和1.76%,两种感染在男性和已婚参与者中的血清流行率更高。输血在统计学上是HCV感染的一个显著危险因素(<0.05)。在来医院就诊的个体中,0.16%的人同时感染了HBV/HCV。
医院人群中HBV和HCV的血清流行率较高,这就要求对高危个体进行筛查。通过健康教育提高对安全性行为的认识以及提高血液及其制品的安全性是控制HBV和HCV感染最重要的预防措施之一。